Study results show high treatment discontinuation and low adherence among US adults with painful diabetic peripheral neuropathy.

Oculis Holding AG shares plunged >35% after both Phase 3 DIAMOND trials for OCS-01 in diabetic macular edema failed primary ...

Adding encorafenib and cetuximab to chemotherapy backbone also prolonged overall survival ...

From dementia to heart attacks, hearing loss has been linked to a wide range of effects across the body, and the condition is ...

Oculis said it will not pursue US Food and Drug Administration (FDA) filing for OCS-01 in diabetic macular edema following ...

Women with breast cancer could be spared chemotherapy thanks to a new genetic test. A breakthrough trial has found that women ...

Cross Keys Capital, LLC, a leading independent investment banking firm providing M&A advisory services to physician group practices and healthcare services companies,is pleased to announce it acted as ...

The study does not say that Wegovy directly causes blindness. Instead, researchers found a strong link between the drug and a ...

Long-term safety was stable without emergent signals; grade ≥3 TRAEs stayed ~57–59%, while cumulative neuropathy increased with duration, managed via interruptions and EV dose reductions. Notably, ...

Justo Betancourt spent six months in federal immigration detention.

Two nights before the data were announced, “transformative” was the word used to describe the results for RASolute 302 ...